Aerie, Deerfield reach $125 million debt financing agreement

Aerie Pharmaceuticals announced it has received a $125 million financing commitment from Deerfield Management Company that is expected to be funded before the end of the month, subject to customary closing conditions.With the financing provided by Deerfield, a current Aerie shareholder, the company plans to continue the advancement of development activities for its clinical-stage product pipeline, general corporate purposes and strategic growth opportunities, according to a press release from Aerie.